Arete Wealth Advisors’s ProShares UltraShort Health Care RXD Stock Holding History

Arete Wealth Advisors’s Portfolio RXD Stock Details RXD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-107,099	Closed	-$3.48M	–	363
2026 Q1	$3.48M	Buy	+107,099	New	+$1.97M	0.26%	95

Other funds holding RXD

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Arete Wealth Advisors's RXD Position: Q2 2026 in Review

Arete Wealth Advisors sold out of ProShares UltraShort Health Care (RXD) in Q2 2026, closing a stake of 107,099 shares — an estimated $3.48M sold.

Arete Wealth Advisors first reported a position in RXD in Q1 2026 and held it in 1 quarter. The position peaked at $3.48M in Q1 2026. 3 funds tracked by Wall St. Rank hold RXD as of Q2 2026.

Arete Wealth Advisors reported no remaining ProShares UltraShort Health Care position as of Q2 2026 after selling out during the quarter.
Arete Wealth Advisors sold 107,099 ProShares UltraShort Health Care shares in Q2 2026, an estimated $3.48M.
Arete Wealth Advisors first reported a position in ProShares UltraShort Health Care in Q1 2026 and held it in 1 quarter.
Arete Wealth Advisors's ProShares UltraShort Health Care position peaked at $3.48M in Q1 2026.
3 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q2 2026.

Based on Arete Wealth Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.